ABSTRACT
Curative therapy for childhood cancers poses the risk of long-term complications, necessitating regular lifelong follow-up for survivors. The Children’s Oncology Group (COG) has issued guidelines on this topic (www.survivorshipguidelines.org). This review summarizes the findings of the COG Guideline Task Force on Pulmonary Complications with respect to pulmonary toxicity.
Footnotes
↵* Dr. Morris has disclosed that he has received consulting fees from the Radiosurgery Centers Corporation and that he owns stock in Amgen, Anesiva, and Synarc corporations.
- Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.